dc.contributor.author | Hamza, Bashar | |
dc.contributor.author | Miller, Alex B. | |
dc.contributor.author | Meier, Lara | |
dc.contributor.author | Stockslager, Max | |
dc.contributor.author | Ng, Sheng Rong | |
dc.contributor.author | King, Emily M. | |
dc.contributor.author | Lin, Lin | |
dc.contributor.author | DeGouveia, Kelsey L. | |
dc.contributor.author | Mulugeta, Nolawit | |
dc.contributor.author | Calistri, Nicholas L. | |
dc.contributor.author | Strouf, Haley | |
dc.contributor.author | Bray, Christina | |
dc.contributor.author | Rodriguez, Felicia | |
dc.contributor.author | Freed-Pastor, William A. | |
dc.contributor.author | Chin, Christopher R. | |
dc.contributor.author | Jaramillo, Grissel C. | |
dc.contributor.author | Burger, Megan L. | |
dc.contributor.author | Weinberg, Robert A. | |
dc.contributor.author | Shalek, Alex K. | |
dc.contributor.author | Jacks, Tyler | |
dc.contributor.author | Manalis, Scott R. | |
dc.date.accessioned | 2022-05-23T14:42:27Z | |
dc.date.available | 2022-03-18T14:10:25Z | |
dc.date.available | 2022-05-23T14:42:27Z | |
dc.date.issued | 2021-09 | |
dc.date.submitted | 2020-10 | |
dc.identifier.issn | 2041-1723 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/141280.2 | |
dc.description.abstract | <jats:title>Abstract</jats:title><jats:p>Existing preclinical methods for acquiring dissemination kinetics of rare circulating tumor cells (CTCs) en route to forming metastases have not been capable of providing a direct measure of CTC intravasation rate and subsequent half-life in the circulation. Here, we demonstrate an approach for measuring endogenous CTC kinetics by continuously exchanging CTC-containing blood over several hours between un-anesthetized, tumor-bearing mice and healthy, tumor-free counterparts. By tracking CTC transfer rates, we extrapolated half-life times in the circulation of between 40 and 260 s and intravasation rates between 60 and 107,000 CTCs/hour in mouse models of small-cell lung cancer (SCLC), pancreatic ductal adenocarcinoma (PDAC), and non-small cell lung cancer (NSCLC). Additionally, direct transfer of only 1−2% of daily-shed CTCs using our blood-exchange technique from late-stage, SCLC-bearing mice generated macrometastases in healthy recipient mice. We envision that our technique will help further elucidate the role of CTCs and the rate-limiting steps in metastasis.</jats:p> | en_US |
dc.language.iso | en | |
dc.publisher | Springer Science and Business Media LLC | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1038/s41467-021-25917-5 | en_US |
dc.rights | Creative Commons Attribution 4.0 International license | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_US |
dc.source | Nature | en_US |
dc.title | Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Hamza, Bashar, Miller, Alex B, Meier, Lara, Stockslager, Max, Ng, Sheng Rong et al. 2021. "Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice." Nature Communications, 12 (1). | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science | |
dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | |
dc.contributor.department | Harvard University--MIT Division of Health Sciences and Technology | |
dc.contributor.department | Massachusetts Institute of Technology. Institute for Medical Engineering & Science | |
dc.contributor.department | Massachusetts Institute of Technology. Department of Mechanical Engineering | |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biology | |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biological Engineering | |
dc.contributor.department | Whitehead Institute for Biomedical Research | |
dc.contributor.department | Massachusetts Institute of Technology. Department of Chemistry | |
dc.contributor.department | Ragon Institute of MGH, MIT and Harvard | |
dc.contributor.department | Ludwig Center for Molecular Oncology (Massachusetts Institute of Technology) | |
dc.relation.journal | Nature Communications | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2022-03-18T14:02:49Z | |
dspace.orderedauthors | Hamza, B; Miller, AB; Meier, L; Stockslager, M; Ng, SR; King, EM; Lin, L; DeGouveia, KL; Mulugeta, N; Calistri, NL; Strouf, H; Bray, C; Rodriguez, F; Freed-Pastor, WA; Chin, CR; Jaramillo, GC; Burger, ML; Weinberg, RA; Shalek, AK; Jacks, T; Manalis, SR | en_US |
dspace.date.submission | 2022-03-18T14:02:52Z | |
mit.journal.volume | 12 | en_US |
mit.journal.issue | 1 | en_US |
mit.license | PUBLISHER_CC | |
mit.metadata.status | Authority Work Needed | en_US |